ROLE OF PLATINUM-DNA ADDUCT FORMATION AND REMOVAL IN CISPLATIN RESISTANCE IN HUMAN OVARIAN-CANCER CELL-LINES

被引:117
作者
JOHNSON, SW
PEREZ, RP
GODWIN, AK
YEUNG, AT
HANDEL, LM
OZOLS, RF
HAMILTON, TC
机构
[1] FOX CHASE CANC CTR, DEPT MED ONCOL, PHILADELPHIA, PA 19111 USA
[2] FOX CHASE CANC CTR, INST CANC RES, PHILADELPHIA, PA 19111 USA
关键词
DNA REPAIR; DRUG RESISTANCE; CISPLATIN; OVARIAN CANCER;
D O I
10.1016/0006-2952(94)90132-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of cisplatin-resistant cell lines were used to examine the formation and removal of platinum-DNA adducts from the overall genome and the formation and removal of cisplatin-interstrand cross-links from specific genomic regions. Cisplatin accumulation and DNA platination levels, which correlated linearly, were similar in three of the resistant cell lines despite differences in their primary cisplatin resistance. Increased platinum removal from total genomic DNA was found to be associated with increased resistance. Interstrand cross-link levels were found to be 2- to 4-fold lower in the 28S ribosomal RNA gene and a non-coding genomic region of the resistant cell lines as compared with the parental A2780 cell line. In addition, 1.2- to 2.7-fold more cross-links were formed in the non-coding region than in the ribosomal RNA gene in all of the cell lines. Interstrand cross-links were removed more rapidly for both regions of the highly cisplatin-resistant C80 and C200 cells and from the ribosomal RNA gene only in the cell lines of lower resistance. The results support a role for DNA repair and alterations in interstrand cross-link formation in cisplatin resistance and provide evidence for heterogeneous interstrand cross-link formation in the genome.
引用
收藏
页码:689 / 697
页数:9
相关论文
共 45 条
[1]   NITROGEN MUSTARD-DNA INTERACTION IN MELPHALAN-RESISTANT MAMMARY-CARCINOMA CELLS WITH ELEVATED INTRACELLULAR GLUTATHIONE AND GLUTATHIONE-S-TRANSFERASE ACTIVITY [J].
ALAOUIJAMALI, MA ;
PANASCI, L ;
CENTURIONI, GM ;
SCHECTER, R ;
LEHNERT, S ;
BATIST, G .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (05) :341-347
[2]   RAPID EMERGENCE OF ACQUIRED CIS-DIAMMINEDICHLOROPLATINUM(II) RESISTANCE IN AN INVIVO MODEL OF HUMAN OVARIAN-CARCINOMA [J].
ANDREWS, PA ;
JONES, JA ;
VARKI, NM ;
HOWELL, SB .
CANCER COMMUNICATIONS-US, 1990, 2 (02) :93-100
[3]  
ANDREWS PA, 1988, CANCER RES, V48, P68
[4]  
ANDREWS PA, 1987, CANCER CHEMOTH PHARM, V19, P149
[5]   SERIAL DETERMINATIONS OF GLUTATHIONE LEVELS AND GLUTATHIONE-RELATED ENZYME-ACTIVITIES IN HUMAN-TUMOR CELLS-INVITRO [J].
BATIST, G ;
BEHRENS, BC ;
MAKUCH, R ;
HAMILTON, TC ;
KATKI, AG ;
LOUIE, KG ;
MYERS, CE ;
OZOLS, RF .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (13) :2257-2258
[6]  
BEHRENS BC, 1987, CANCER RES, V47, P414
[7]   GENE SPECIFIC DNA-REPAIR [J].
BOHR, VA .
CARCINOGENESIS, 1991, 12 (11) :1983-1992
[8]   CELLULAR GLUTATHIONE (GSH) AND GLUTATHIONE-S-TRANSFERASE (GST) ACTIVITY IN HUMAN OVARIAN TUMOR-BIOPSIES FOLLOWING EXPOSURE TO ALKYLATING-AGENTS [J].
BRITTEN, RA ;
GREEN, JA ;
WARENIUS, HM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 24 (03) :527-531
[9]   TRANSCRIPTION-DEPENDENT AND INDEPENDENT DNA EXCISION REPAIR PATHWAYS IN HUMAN-CELLS [J].
CARREAU, M ;
HUNTING, D .
MUTATION RESEARCH, 1992, 274 (01) :57-64
[10]   INHIBITION OF TRANSCRIPTION AND STRAND-SPECIFIC DNA-REPAIR BY ALPHA-AMANITIN IN CHINESE-HAMSTER OVARY CELLS [J].
CHRISTIANS, FC ;
HANAWALT, PC .
MUTATION RESEARCH, 1992, 274 (02) :93-101